About Pharmerit
Data last updated:
Pharmerit is a company based in Berlin (Germany) founded in 2000. It operates as a B2B. Pharmerit operates in a competitive market with competitors including OPEN Health, Target RWE, Secura Bio, STATinMED Research and Abacus Medicine, among others.
- Headquarter Berlin, Germany
- SectorsHealthcare
- Website pharmerit.com
- Social X Facebook
- Legal Name Pharmerit India Private Limited
- Date of Incorporation 21 Dec, 2018
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue$716.98 K (USD)79.3as on Mar 31, 2022
- Net Profit$245.96 K (USD)70.32as on Mar 31, 2022
- EBITDA$470.97 K (USD)42.91as on Mar 31, 2022
Associated legal entities of Pharmerit
Pharmerit operates through Pharmerit India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors |
|---|---|---|---|---|---|---|
| Pharmerit India Private Limited Primary CIN U93090MH2018FTC318679 | Active | 21 Dec 2018 | Mumbai, Maharashtra | ₹6.4 Cr | – | 3 |
Board of directors of Pharmerit India Private Limited (Pharmerit)
Pharmerit India Private Limited is the primary company behind Pharmerit. The board of Pharmerit India Private Limited currently have 3 directors; the longest-serving is Jennifer Means Stephens, appointed in 2018. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jennifer Means Stephens DIN 08311667 | Director | 21 Dec 2018 | 7 yrs 9 mo | Pharmerit India Private Limited |
| Tejas Manharlal Shah DIN 10792657 | Director | 29 Sep 2024 | 2 yrs | Pharmerit India Private Limited |
| Richard Jones DIN 11076495 | Director | 16 May 2025 | 1 yr 4 mo | Pharmerit India Private Limited |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Financials of Pharmerit
Figures of Pharmerit India Private Limited, the primary company behind Pharmerit, for FY 2025. Revenue was ₹6.39 Cr (-65% year on year). Net profit was ₹1.37 Cr (21% margin). EBITDA was ₹1.99 Cr (31% margin). Revenue has grown at a compounded annual rate of +3% over three years and +12% over five years.
- ₹6.39 CrRevenue · FY 2025 · -65% YoY
- ₹1.37 CrNet profit · 21% margin
- ₹1.99 CrEBITDA · 31% margin
- ₹0.01 CrPaid-up capital
- +3%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pharmerit India Private Limited are on its company page.
Detailed financial statements for Pharmerit
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Pharmerit
Pharmerit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OPEN Health, Target RWE, Secura Bio, STATinMED Research and Abacus Medicine, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| openhealthgroup.com | 2016 | Marlow, United Kingdom | $5.3M | 297 | Provider of healthcare marketing services | |
| targetrwe.com | 2017 | Durham, United States | – | 116 | Marketing services to the pharmaceutical industry are provided. | |
| securabio.com | 2018 | Henderson, United States | $55.0M | – | Consulting services for market access and health outcomes are provided. | |
| statinmed.com | 2007 | Ann Arbor, United States | – | – | Healthcare data analytics services provider | |
| abacusmedicine.com | 2004 | Copenhagen, Denmark | $57.6M | 1,052 | Consulting services for market access, health economics and outcomes research | |
| vitaccess.com | 2002 | Oxford, United Kingdom | – | 40 | Provider of market access & HEOR consulting services for pharmaceutical industries | |
| hylant.com | 1935 | Toledo, United States | – | 849 | Offers business insurance, employee benefits, and risk consulting services worldwide. | |
| gba-group.com | 1975 | Hamburg, Germany | – | – | GBA Group is recognized as a leading life sciences service provider. |
Detailed competitors of Pharmerit
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmerit
Complete news archive for Pharmerit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmerit
Pharmerit was founded in 2000.
Pharmerit is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Annual revenue of Pharmerit is $716.98K as on Mar 31, 2022.
Pharmerit provides comprehensive market access and data management solutions for healthcare and related industries through providing healthcare solutions, biotechnology and pharmaceuticals, market access, and data management services. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
Pharmerit's top competitors include OPEN Health, Abacus Medicine and Target RWE.
Pharmerit operates through Pharmerit India Private Limited.
The legal entities of Pharmerit currently have 3 directors, including Tejas Manharlal Shah, Jennifer Means Stephens, Richard Jones.